C0432487||Post-transplant lymphoproliferative disease
C2063401||lung transplant recipients
C0010674||cystic fibrosis
C0432487||Post-transplant lymphoproliferative disease
C0432487||Post-transplant lymphoproliferative disease
C0024128||lung transplantation
C0010674||cystic fibrosis
C0010674||cystic fibrosis
C0432487||Post-transplant lymphoproliferative disease
C0023866||literature
C0599755||single center cohorts
C0432487||Post-transplant lymphoproliferative disease
C0024128||lung transplant
C1257890||population
C0282574||International Society for Heart and Lung Transplantation Registry
C2603343||studied
C1709854||recipients
C0024128||lung transplants
C0432487||Post-transplant lymphoproliferative disease
C0040732||transplant
C0014644||Epstein-Barr virus
C0014644||Epstein-Barr virus
C0010825||cytomegalovirus
C0010825||cytomegalovirus
C1300950||serostatus
C0010235||multivariable Cox proportional hazard models
C0599755||cohort
C0011900||diagnosis
C0010674||cystic fibrosis
C0432487||Post-transplant lymphoproliferative disease
C0010674||cystic fibrosis
C2063401||non-CF recipients
C2063401||non-CF recipients
C0010674||cystic fibrosis
C0014644||Epstein-Barr virus
C2919629||CMV seronegativity
C0014644||Epstein-Barr virus
C0010825||cytomegalovirus
C0010674||cystic fibrosis
C0432487||Post-transplant lymphoproliferative disease
C0014644||Epstein-Barr virus
C1513916||negative
C2063401||non-CF recipients
C0432487||Post-transplant lymphoproliferative disease
C0014644||Epstein-Barr virus
C0010674||cystic fibrosis
C0010674||cystic fibrosis
C0432487||Post-transplant lymphoproliferative disease
C2063401||non-CF recipients
C2603343||studies
C0035648||risk factors
C0035649||management
C2063401||population post-transplant